Familial hypercholesterolaemia: clinical features and management.
Coronary heart disease is the leading cause of mortality and morbidity in the UK, for which hypercholesterolaemia is a risk factor. This article concentrates on the management of patients with familial hypercholesterolaemia (FH). It discusses FH, how it is diagnosed, and the treatments that are available.
Pottle
Alison
A
Harefield Hospital, Royal Brompton and Harefield NHS Trust, Harefield, Middlesex. a.pottle@rbht.nhs.uk
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D004032:Diet; D004496:Education, Continuing; D005817:Genetic Counseling; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D011973:Receptors, LDL / Q000378:metabolism
D000924:Anticholesteremic Agents; D011973:Receptors, LDL; D002784:Cholesterol